7 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
News 2026-09-28 12:58 UTC
On Thursday, Legence (NASDAQ: LGN ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered APIs. For comprehensive financial data and transcripts, visit View the webcast at Summary Legence reported Q2 2026 revenue of $1.3 billion, a 111% incre
News 2026-09-17 10:31 UTC
Vale (NYSE: VALE ) held its second-quarter earnings conference call on Friday. Below is the complete transcript from the call. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. View the webcast at Summary Vale S.A. reported a strong Q2 2026 performance, with a 19% incre
News 2026-09-17 07:30 UTC
Equinor (NYSE: EQNR ) reported second-quarter financial results on Wednesday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. The full earnings call is available a
News 2026-09-10 14:04 UTC
D2L said second-quarter revenue rose 2% to $55.6 million and annual recurring revenue increased 5% to $223.4 million. Management also cited U.S. K-12 churn, revised full-year revenue growth guidance lower and left EBITDA guidance unchanged.
News 2026-09-10 13:25 UTC
The company said second-quarter revenue rose 30.1% year over year to 1.39 billion RMB, while net income increased 35.6% to 413.2 million RMB. Yuanbao also said cash reserves totaled 5.16 billion RMB and it had repurchased about 114,000 ADS for US$1.6 million as of Aug. 31, 2026.
News 2026-09-03 21:44 UTC
Lululemon reported second-quarter revenue of $2.4 billion, down 4% year over year, and lowered full-year revenue guidance to $10.35 billion-$10.5 billion, citing softer sales trends and inconsistent product launch performance.
News 2026-08-06 11:29 UTC
OPEN Technologies target lowered to $7